A Subset of Malignant Phyllodes Tumors Express p63 and p40
Identifieur interne : 002E43 ( Main/Exploration ); précédent : 002E42; suivant : 002E44A Subset of Malignant Phyllodes Tumors Express p63 and p40
Auteurs : Ashley Cimino-Mathews ; Rajni Sharma ; Peter B. Illei ; Russell Vang ; Pedram ArganiSource :
- The American journal of surgical pathology [ 0147-5185 ] ; 2014.
Abstract
Breast phyllodes tumors are rare fibroepithelial neoplasms of variable grade, and one key differential of malignant phyllodes on core biopsy is sarcomatoid carcinoma. p63 is reported to be sensitive and specific for sarcomatoid carcinoma, with rare expression in phyllodes in limited series. The p63 deltaNp63 isoform, p40, is postulated to be more specific for squamous differentiation but has not previously been evaluated in breast phyllodes or sarcomatoid carcinoma. Tissue microarrays containing 34 unambiguous phyllodes tumors (10 benign, 10 borderline, 14 malignant), 13 sarcomatoid carcinomas, and 10 fibroadenomas were labeled by immunohistochemistry for p63, p40, CD34, and cytokeratins AE1/AE3, 34betaE12, and CK8/18. No borderline phyllodes tumor, benign phyllodes tumor, or fibroadenoma labeled with p63, p40, or cytokeratin. However, p63 labeled 57% malignant phyllodes tumors and 62% sarcomatoid carcinomas, and p40 labeled 29% malignant phyllodes (focal) and 46% sarcomatoid carcinomas. Among established markers, cytokeratins labeled 21% malignant phyllodes tumors (focal) and 100% sarcomatoid carcinomas. CD34 labeled 57% malignant phyllodes tumors and no sarcomatoid carcinomas. Focal p63, p40, and cytokeratin labeling can be seen in malignant phyllodes tumors but not in lowergrade fibroepithelial lesions, and immunoreactivity with these markers alone is not diagnostic of sarcomatoid carcinoma on core needle biopsy. In the differential diagnosis of malignant phyllodes, p40 is a more specific but less sensitive marker of sarcomatoid carcinoma than p63. These results are consistent with the sarcoma literature in which p63 labeling has been increasingly reported and suggest caution in classifying malignant spindle cell tumors of the breast on core biopsy.
Url:
DOI: 10.1097/PAS.0000000000000301
PubMed: 25046342
PubMed Central: 4373607
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 003699
- to stream Pmc, to step Curation: 003698
- to stream Pmc, to step Checkpoint: 001E12
- to stream Ncbi, to step Merge: 006879
- to stream Ncbi, to step Curation: 006879
- to stream Ncbi, to step Checkpoint: 006879
- to stream Main, to step Merge: 002E48
- to stream Main, to step Curation: 002E43
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Subset of Malignant Phyllodes Tumors Express p63 and p40</title>
<author><name sortKey="Cimino Mathews, Ashley" sort="Cimino Mathews, Ashley" uniqKey="Cimino Mathews A" first="Ashley" last="Cimino-Mathews">Ashley Cimino-Mathews</name>
</author>
<author><name sortKey="Sharma, Rajni" sort="Sharma, Rajni" uniqKey="Sharma R" first="Rajni" last="Sharma">Rajni Sharma</name>
</author>
<author><name sortKey="Illei, Peter B" sort="Illei, Peter B" uniqKey="Illei P" first="Peter B." last="Illei">Peter B. Illei</name>
</author>
<author><name sortKey="Vang, Russell" sort="Vang, Russell" uniqKey="Vang R" first="Russell" last="Vang">Russell Vang</name>
</author>
<author><name sortKey="Argani, Pedram" sort="Argani, Pedram" uniqKey="Argani P" first="Pedram" last="Argani">Pedram Argani</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">25046342</idno>
<idno type="pmc">4373607</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373607</idno>
<idno type="RBID">PMC:4373607</idno>
<idno type="doi">10.1097/PAS.0000000000000301</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">003699</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003699</idno>
<idno type="wicri:Area/Pmc/Curation">003698</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003698</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001E12</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001E12</idno>
<idno type="wicri:Area/Ncbi/Merge">006879</idno>
<idno type="wicri:Area/Ncbi/Curation">006879</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">006879</idno>
<idno type="wicri:doubleKey">0147-5185:2014:Cimino Mathews A:a:subset:of</idno>
<idno type="wicri:Area/Main/Merge">002E48</idno>
<idno type="wicri:Area/Main/Curation">002E43</idno>
<idno type="wicri:Area/Main/Exploration">002E43</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">A Subset of Malignant Phyllodes Tumors Express p63 and p40</title>
<author><name sortKey="Cimino Mathews, Ashley" sort="Cimino Mathews, Ashley" uniqKey="Cimino Mathews A" first="Ashley" last="Cimino-Mathews">Ashley Cimino-Mathews</name>
</author>
<author><name sortKey="Sharma, Rajni" sort="Sharma, Rajni" uniqKey="Sharma R" first="Rajni" last="Sharma">Rajni Sharma</name>
</author>
<author><name sortKey="Illei, Peter B" sort="Illei, Peter B" uniqKey="Illei P" first="Peter B." last="Illei">Peter B. Illei</name>
</author>
<author><name sortKey="Vang, Russell" sort="Vang, Russell" uniqKey="Vang R" first="Russell" last="Vang">Russell Vang</name>
</author>
<author><name sortKey="Argani, Pedram" sort="Argani, Pedram" uniqKey="Argani P" first="Pedram" last="Argani">Pedram Argani</name>
</author>
</analytic>
<series><title level="j">The American journal of surgical pathology</title>
<idno type="ISSN">0147-5185</idno>
<idno type="eISSN">1532-0979</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Breast phyllodes tumors are rare fibroepithelial neoplasms of variable grade, and one key differential of malignant phyllodes on core biopsy is sarcomatoid carcinoma. p63 is reported to be sensitive and specific for sarcomatoid carcinoma, with rare expression in phyllodes in limited series. The p63 deltaNp63 isoform, p40, is postulated to be more specific for squamous differentiation but has not previously been evaluated in breast phyllodes or sarcomatoid carcinoma. Tissue microarrays containing 34 unambiguous phyllodes tumors (10 benign, 10 borderline, 14 malignant), 13 sarcomatoid carcinomas, and 10 fibroadenomas were labeled by immunohistochemistry for p63, p40, CD34, and cytokeratins AE1/AE3, 34betaE12, and CK8/18. No borderline phyllodes tumor, benign phyllodes tumor, or fibroadenoma labeled with p63, p40, or cytokeratin. However, p63 labeled 57% malignant phyllodes tumors and 62% sarcomatoid carcinomas, and p40 labeled 29% malignant phyllodes (focal) and 46% sarcomatoid carcinomas. Among established markers, cytokeratins labeled 21% malignant phyllodes tumors (focal) and 100% sarcomatoid carcinomas. CD34 labeled 57% malignant phyllodes tumors and no sarcomatoid carcinomas. Focal p63, p40, and cytokeratin labeling can be seen in malignant phyllodes tumors but not in lowergrade fibroepithelial lesions, and immunoreactivity with these markers alone is not diagnostic of sarcomatoid carcinoma on core needle biopsy. In the differential diagnosis of malignant phyllodes, p40 is a more specific but less sensitive marker of sarcomatoid carcinoma than p63. These results are consistent with the sarcoma literature in which p63 labeling has been increasingly reported and suggest caution in classifying malignant spindle cell tumors of the breast on core biopsy.</p>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Argani, Pedram" sort="Argani, Pedram" uniqKey="Argani P" first="Pedram" last="Argani">Pedram Argani</name>
<name sortKey="Cimino Mathews, Ashley" sort="Cimino Mathews, Ashley" uniqKey="Cimino Mathews A" first="Ashley" last="Cimino-Mathews">Ashley Cimino-Mathews</name>
<name sortKey="Illei, Peter B" sort="Illei, Peter B" uniqKey="Illei P" first="Peter B." last="Illei">Peter B. Illei</name>
<name sortKey="Sharma, Rajni" sort="Sharma, Rajni" uniqKey="Sharma R" first="Rajni" last="Sharma">Rajni Sharma</name>
<name sortKey="Vang, Russell" sort="Vang, Russell" uniqKey="Vang R" first="Russell" last="Vang">Russell Vang</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E43 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002E43 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:4373607 |texte= A Subset of Malignant Phyllodes Tumors Express p63 and p40 }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25046342" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |